nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ACHE—kidney cancer	0.604	0.629	CbGaD
Dipivefrin—BCHE—kidney cancer	0.355	0.37	CbGaD
Dipivefrin—Bambuterol—BCHE—kidney cancer	0.00426	1	CrCbGaD
Dipivefrin—Conjunctivitis—Temsirolimus—kidney cancer	0.000317	0.0503	CcSEcCtD
Dipivefrin—Conjunctivitis—Everolimus—kidney cancer	0.000236	0.0374	CcSEcCtD
Dipivefrin—Conjunctivitis—Erlotinib—kidney cancer	0.000227	0.0361	CcSEcCtD
Dipivefrin—Hypertension—Temsirolimus—kidney cancer	0.00022	0.0349	CcSEcCtD
Dipivefrin—Hypertension—Pazopanib—kidney cancer	0.000207	0.0329	CcSEcCtD
Dipivefrin—Arrhythmia—Erlotinib—kidney cancer	0.000187	0.0298	CcSEcCtD
Dipivefrin—Pain—Temsirolimus—kidney cancer	0.000178	0.0282	CcSEcCtD
Dipivefrin—Arrhythmia—Sorafenib—kidney cancer	0.000169	0.0268	CcSEcCtD
Dipivefrin—Pain—Pazopanib—kidney cancer	0.000167	0.0266	CcSEcCtD
Dipivefrin—Hypertension—Vinblastine—kidney cancer	0.000164	0.0261	CcSEcCtD
Dipivefrin—Hypertension—Everolimus—kidney cancer	0.000163	0.026	CcSEcCtD
Dipivefrin—Arrhythmia—Sunitinib—kidney cancer	0.000162	0.0258	CcSEcCtD
Dipivefrin—Stinging—Doxorubicin—kidney cancer	0.000159	0.0252	CcSEcCtD
Dipivefrin—Hypersensitivity—Temsirolimus—kidney cancer	0.000153	0.0243	CcSEcCtD
Dipivefrin—Tachycardia—Everolimus—kidney cancer	0.000151	0.024	CcSEcCtD
Dipivefrin—Hypertension—Sorafenib—kidney cancer	0.000142	0.0225	CcSEcCtD
Dipivefrin—Hypertension—Sunitinib—kidney cancer	0.000137	0.0217	CcSEcCtD
Dipivefrin—Pain—Vinblastine—kidney cancer	0.000133	0.0211	CcSEcCtD
Dipivefrin—Conjunctivitis—Paclitaxel—kidney cancer	0.000132	0.021	CcSEcCtD
Dipivefrin—Pain—Everolimus—kidney cancer	0.000132	0.021	CcSEcCtD
Dipivefrin—Arrhythmia—Gemcitabine—kidney cancer	0.00013	0.0207	CcSEcCtD
Dipivefrin—Pain—Erlotinib—kidney cancer	0.000128	0.0203	CcSEcCtD
Dipivefrin—Hypertension—Vincristine—kidney cancer	0.000115	0.0183	CcSEcCtD
Dipivefrin—Pain—Sorafenib—kidney cancer	0.000115	0.0182	CcSEcCtD
Dipivefrin—Hypersensitivity—Vinblastine—kidney cancer	0.000114	0.0182	CcSEcCtD
Dipivefrin—Hypersensitivity—Everolimus—kidney cancer	0.000114	0.0181	CcSEcCtD
Dipivefrin—Pain—Sunitinib—kidney cancer	0.00011	0.0175	CcSEcCtD
Dipivefrin—Hypertension—Gemcitabine—kidney cancer	0.00011	0.0174	CcSEcCtD
Dipivefrin—Arrhythmia—Paclitaxel—kidney cancer	0.000109	0.0173	CcSEcCtD
Dipivefrin—Conjunctivitis—Capecitabine—kidney cancer	0.000108	0.0172	CcSEcCtD
Dipivefrin—Pain—Dactinomycin—kidney cancer	0.000104	0.0166	CcSEcCtD
Dipivefrin—Hypersensitivity—Sorafenib—kidney cancer	9.88e-05	0.0157	CcSEcCtD
Dipivefrin—Hypersensitivity—Sunitinib—kidney cancer	9.51e-05	0.0151	CcSEcCtD
Dipivefrin—Pain—Vincristine—kidney cancer	9.34e-05	0.0148	CcSEcCtD
Dipivefrin—Hypertension—Paclitaxel—kidney cancer	9.17e-05	0.0146	CcSEcCtD
Dipivefrin—Hypersensitivity—Dactinomycin—kidney cancer	9e-05	0.0143	CcSEcCtD
Dipivefrin—Arrhythmia—Capecitabine—kidney cancer	8.95e-05	0.0142	CcSEcCtD
Dipivefrin—Pain—Gemcitabine—kidney cancer	8.86e-05	0.0141	CcSEcCtD
Dipivefrin—Tachycardia—Paclitaxel—kidney cancer	8.46e-05	0.0134	CcSEcCtD
Dipivefrin—Hypersensitivity—Vincristine—kidney cancer	8.04e-05	0.0128	CcSEcCtD
Dipivefrin—Hypertension—Capecitabine—kidney cancer	7.53e-05	0.012	CcSEcCtD
Dipivefrin—Pain—Paclitaxel—kidney cancer	7.42e-05	0.0118	CcSEcCtD
Dipivefrin—Conjunctivitis—Doxorubicin—kidney cancer	6.99e-05	0.0111	CcSEcCtD
Dipivefrin—Tachycardia—Capecitabine—kidney cancer	6.95e-05	0.011	CcSEcCtD
Dipivefrin—Hypersensitivity—Paclitaxel—kidney cancer	6.39e-05	0.0101	CcSEcCtD
Dipivefrin—Pain—Capecitabine—kidney cancer	6.09e-05	0.00967	CcSEcCtD
Dipivefrin—Arrhythmia—Doxorubicin—kidney cancer	5.77e-05	0.00916	CcSEcCtD
Dipivefrin—Hypersensitivity—Capecitabine—kidney cancer	5.24e-05	0.00833	CcSEcCtD
Dipivefrin—Hypertension—Doxorubicin—kidney cancer	4.85e-05	0.00771	CcSEcCtD
Dipivefrin—Tachycardia—Doxorubicin—kidney cancer	4.48e-05	0.00711	CcSEcCtD
Dipivefrin—Pain—Doxorubicin—kidney cancer	3.92e-05	0.00623	CcSEcCtD
Dipivefrin—Hypersensitivity—Doxorubicin—kidney cancer	3.38e-05	0.00537	CcSEcCtD
Dipivefrin—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	1.19e-05	0.000392	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	1.19e-05	0.00039	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—BCHE—kidney cancer	1.17e-05	0.000384	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—MAPK3—kidney cancer	1.17e-05	0.000383	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—POMC—kidney cancer	1.16e-05	0.000381	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SLC5A5—kidney cancer	1.16e-05	0.000379	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—VEGFA—kidney cancer	1.15e-05	0.000379	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000377	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GSTP1—kidney cancer	1.15e-05	0.000376	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PAK1—kidney cancer	1.14e-05	0.000374	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—JUNB—kidney cancer	1.14e-05	0.000374	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—POMC—kidney cancer	1.13e-05	0.00037	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CTNNA1—kidney cancer	1.12e-05	0.000367	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SLC2A1—kidney cancer	1.12e-05	0.000366	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—POMC—kidney cancer	1.11e-05	0.000366	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—MAPK1—kidney cancer	1.11e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TSC1—kidney cancer	1.11e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	1.11e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	1.11e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HSPB1—kidney cancer	1.11e-05	0.000364	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EIF4EBP1—kidney cancer	1.11e-05	0.000364	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—IL2—kidney cancer	1.1e-05	0.000362	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—MAPK3—kidney cancer	1.09e-05	0.000358	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ABCB1—kidney cancer	1.08e-05	0.000356	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FLT1—kidney cancer	1.08e-05	0.000353	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.06e-05	0.000347	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—POMC—kidney cancer	1.05e-05	0.000346	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GSTM1—kidney cancer	1.05e-05	0.000346	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—KRAS—kidney cancer	1.05e-05	0.000345	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—MAPK1—kidney cancer	1.04e-05	0.000341	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PSMD7—kidney cancer	1.03e-05	0.000339	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TSC1—kidney cancer	1.03e-05	0.000339	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ANXA1—kidney cancer	1.03e-05	0.000339	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	1.01e-05	0.000333	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FLT1—kidney cancer	9.99e-06	0.000328	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CYP1A1—kidney cancer	9.98e-06	0.000328	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF2—kidney cancer	9.98e-06	0.000328	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PAK1—kidney cancer	9.97e-06	0.000327	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—JUNB—kidney cancer	9.97e-06	0.000327	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDKN2B—kidney cancer	9.94e-06	0.000326	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF2—kidney cancer	9.85e-06	0.000324	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDKN2B—kidney cancer	9.81e-06	0.000322	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—KRAS—kidney cancer	9.81e-06	0.000322	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF1R—kidney cancer	9.65e-06	0.000317	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—PIK3CA—kidney cancer	9.64e-06	0.000317	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—POMC—kidney cancer	9.6e-06	0.000315	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF1R—kidney cancer	9.53e-06	0.000313	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.44e-06	0.00031	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—POMC—kidney cancer	9.42e-06	0.000309	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VEGFA—kidney cancer	9.37e-06	0.000308	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TP53—kidney cancer	9.33e-06	0.000306	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF2—kidney cancer	9.32e-06	0.000306	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSTP1—kidney cancer	9.31e-06	0.000306	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—RAF1—kidney cancer	9.3e-06	0.000305	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDKN2B—kidney cancer	9.28e-06	0.000305	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PAK1—kidney cancer	9.26e-06	0.000304	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—JUNB—kidney cancer	9.26e-06	0.000304	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—POMC—kidney cancer	9.21e-06	0.000302	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—IL2—kidney cancer	9.18e-06	0.000301	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—RAF1—kidney cancer	9.18e-06	0.000301	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—IL2—kidney cancer	9.06e-06	0.000298	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF1R—kidney cancer	9.02e-06	0.000296	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—PIK3CA—kidney cancer	9.01e-06	0.000296	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—MAPK3—kidney cancer	8.86e-06	0.000291	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ABCB1—kidney cancer	8.81e-06	0.000289	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TP53—kidney cancer	8.72e-06	0.000286	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—RAF1—kidney cancer	8.69e-06	0.000285	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—IL2—kidney cancer	8.58e-06	0.000282	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—POMC—kidney cancer	8.57e-06	0.000281	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—POMC—kidney cancer	8.56e-06	0.000281	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSTM1—kidney cancer	8.55e-06	0.000281	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—MAPK1—kidney cancer	8.43e-06	0.000277	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL2—kidney cancer	8.34e-06	0.000274	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL2—kidney cancer	8.23e-06	0.00027	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF2—kidney cancer	8.15e-06	0.000268	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	8.12e-06	0.000266	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP1A1—kidney cancer	8.11e-06	0.000266	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—KRAS—kidney cancer	7.96e-06	0.000261	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HIF1A—kidney cancer	7.95e-06	0.000261	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TSC2—kidney cancer	7.93e-06	0.00026	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	7.88e-06	0.000259	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HIF1A—kidney cancer	7.84e-06	0.000258	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TSC2—kidney cancer	7.82e-06	0.000257	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL2—kidney cancer	7.79e-06	0.000256	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTGS2—kidney cancer	7.66e-06	0.000252	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—KDR—kidney cancer	7.6e-06	0.000249	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	7.59e-06	0.000249	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF2—kidney cancer	7.57e-06	0.000249	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDKN2B—kidney cancer	7.54e-06	0.000248	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—KDR—kidney cancer	7.5e-06	0.000246	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	7.5e-06	0.000246	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—POMC—kidney cancer	7.44e-06	0.000244	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HIF1A—kidney cancer	7.42e-06	0.000244	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TSC2—kidney cancer	7.4e-06	0.000243	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF1R—kidney cancer	7.32e-06	0.00024	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—PIK3CA—kidney cancer	7.32e-06	0.00024	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—KDR—kidney cancer	7.1e-06	0.000233	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TP53—kidney cancer	7.08e-06	0.000232	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	7.06e-06	0.000232	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APC—kidney cancer	7e-06	0.00023	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—KIT—kidney cancer	7e-06	0.00023	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	6.97e-06	0.000229	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—KIT—kidney cancer	6.91e-06	0.000227	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APC—kidney cancer	6.91e-06	0.000227	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTGS2—kidney cancer	6.83e-06	0.000224	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL2—kidney cancer	6.81e-06	0.000224	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—MAPK3—kidney cancer	6.7e-06	0.00022	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTEN—kidney cancer	6.68e-06	0.000219	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—POMC—kidney cancer	6.66e-06	0.000219	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—MAPK3—kidney cancer	6.62e-06	0.000217	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—BRAF—kidney cancer	6.58e-06	0.000216	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—POMC—kidney cancer	6.58e-06	0.000216	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APC—kidney cancer	6.54e-06	0.000215	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—KIT—kidney cancer	6.54e-06	0.000215	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—BRAF—kidney cancer	6.5e-06	0.000213	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	6.49e-06	0.000213	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TSC2—kidney cancer	6.47e-06	0.000212	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—MAPK1—kidney cancer	6.38e-06	0.000209	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL2—kidney cancer	6.33e-06	0.000208	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—MAPK1—kidney cancer	6.3e-06	0.000207	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—MAPK3—kidney cancer	6.26e-06	0.000206	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—POMC—kidney cancer	6.22e-06	0.000204	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KDR—kidney cancer	6.2e-06	0.000204	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—BRAF—kidney cancer	6.15e-06	0.000202	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—PIK3CA—kidney cancer	6.09e-06	0.0002	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—POMC—kidney cancer	6.05e-06	0.000198	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	6.03e-06	0.000198	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—KRAS—kidney cancer	6.02e-06	0.000198	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—PIK3CA—kidney cancer	6.02e-06	0.000198	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TSC2—kidney cancer	6.01e-06	0.000197	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTEN—kidney cancer	5.96e-06	0.000196	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—MAPK1—kidney cancer	5.96e-06	0.000196	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—KRAS—kidney cancer	5.95e-06	0.000195	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTGS2—kidney cancer	5.94e-06	0.000195	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KDR—kidney cancer	5.77e-06	0.000189	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APC—kidney cancer	5.72e-06	0.000188	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KIT—kidney cancer	5.72e-06	0.000188	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—PIK3CA—kidney cancer	5.69e-06	0.000187	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—KRAS—kidney cancer	5.63e-06	0.000185	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	5.53e-06	0.000182	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RAF1—kidney cancer	5.49e-06	0.00018	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	5.47e-06	0.00018	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RELA—kidney cancer	5.47e-06	0.00018	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—PIK3CA—kidney cancer	5.46e-06	0.000179	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—POMC—kidney cancer	5.44e-06	0.000179	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	5.43e-06	0.000178	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RAF1—kidney cancer	5.42e-06	0.000178	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RELA—kidney cancer	5.4e-06	0.000177	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—BRAF—kidney cancer	5.37e-06	0.000176	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ERBB2—kidney cancer	5.37e-06	0.000176	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MTOR—kidney cancer	5.36e-06	0.000176	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APC—kidney cancer	5.31e-06	0.000174	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KIT—kidney cancer	5.31e-06	0.000174	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MTOR—kidney cancer	5.3e-06	0.000174	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	5.21e-06	0.000171	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTEN—kidney cancer	5.18e-06	0.00017	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	5.17e-06	0.00017	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RAF1—kidney cancer	5.13e-06	0.000168	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RELA—kidney cancer	5.11e-06	0.000168	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	5.09e-06	0.000167	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	5.08e-06	0.000167	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—POMC—kidney cancer	5.06e-06	0.000166	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	5.03e-06	0.000165	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MTOR—kidney cancer	5.01e-06	0.000164	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—BRAF—kidney cancer	4.99e-06	0.000164	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.98e-06	0.000163	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDKN1B—kidney cancer	4.97e-06	0.000163	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL2—kidney cancer	4.93e-06	0.000162	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.92e-06	0.000162	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL2—kidney cancer	4.86e-06	0.00016	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.84e-06	0.000159	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTGS2—kidney cancer	4.82e-06	0.000158	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCND1—kidney cancer	4.8e-06	0.000158	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—JUN—kidney cancer	4.79e-06	0.000157	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	4.76e-06	0.000156	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCND1—kidney cancer	4.74e-06	0.000156	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—JUN—kidney cancer	4.73e-06	0.000155	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PIK3CA—kidney cancer	4.71e-06	0.000155	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	4.7e-06	0.000154	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CTNNB1—kidney cancer	4.69e-06	0.000154	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PTEN—kidney cancer	4.63e-06	0.000152	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.62e-06	0.000152	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL2—kidney cancer	4.6e-06	0.000151	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PTEN—kidney cancer	4.58e-06	0.00015	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	4.57e-06	0.00015	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.52e-06	0.000148	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.49e-06	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCND1—kidney cancer	4.49e-06	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—JUN—kidney cancer	4.48e-06	0.000147	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.47e-06	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	4.44e-06	0.000146	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.44e-06	0.000146	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.38e-06	0.000144	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PTEN—kidney cancer	4.33e-06	0.000142	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTEN—kidney cancer	4.21e-06	0.000138	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PIK3CA—kidney cancer	4.2e-06	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	4.2e-06	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	4.19e-06	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RAF1—kidney cancer	4.17e-06	0.000137	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RELA—kidney cancer	4.15e-06	0.000136	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—kidney cancer	4.13e-06	0.000136	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	4.12e-06	0.000135	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	4.11e-06	0.000135	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MTOR—kidney cancer	4.07e-06	0.000134	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL2—kidney cancer	4.02e-06	0.000132	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.96e-06	0.00013	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.92e-06	0.000129	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.91e-06	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.91e-06	0.000128	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK3—kidney cancer	3.91e-06	0.000128	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.88e-06	0.000127	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.85e-06	0.000126	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.82e-06	0.000125	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MYC—kidney cancer	3.8e-06	0.000125	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.78e-06	0.000124	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.77e-06	0.000124	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.74e-06	0.000123	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK1—kidney cancer	3.72e-06	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.7e-06	0.000121	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.65e-06	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.64e-06	0.00012	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.64e-06	0.000119	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.61e-06	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.6e-06	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.56e-06	0.000117	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.52e-06	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.52e-06	0.000115	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—KRAS—kidney cancer	3.51e-06	0.000115	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.42e-06	0.000112	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—KRAS—kidney cancer	3.32e-06	0.000109	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	3.27e-06	0.000107	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.23e-06	0.000106	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3CA—kidney cancer	3.23e-06	0.000106	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	3.18e-06	0.000104	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TP53—kidney cancer	3.16e-06	0.000104	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MYC—kidney cancer	3.15e-06	0.000103	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TP53—kidney cancer	3.12e-06	0.000103	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	3.08e-06	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	3.05e-06	0.0001	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	3e-06	9.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.97e-06	9.74e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.95e-06	9.7e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.92e-06	9.59e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.91e-06	9.54e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.86e-06	9.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.7e-06	8.87e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.67e-06	8.77e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.58e-06	8.48e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	8.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.4e-06	7.88e-05	CbGpPWpGaD
